Chemomab Therapeutics To Participate In Oppenheimer 35Th Annual Healthcare Life Sciences Conference
Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique role of the soluble protein CCL24 in ...
Cosmetics Business27m
Give Back Beauty bolsters fragrance portfolio with AB Parfums acquisition
The acquisition of Italy-based AB Parfums, which distributes brands including Viktor & Rolf, aims to strengthen the beauty ...
Fingerprint Cards AB (Fingerprints) Partners With Leading Advisory Firm To Grow IP Commercialization And Defend Its Technology
Fingerprint Cards AB (Fingerprints), a global leader in biometric technology, is pleased to announce a strategic partnership with a leading IP adviso ...
Future Market Insights37m
Probiotic Yogurt Market: Industry Trends, Consumer Preferences, and Forecast by 2033
Probiotics Yogurt is anticipated to become more popular during the forecast period at a CAGR of 8.00%. Market analysts ...